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Abstract
The pathogenesis of complex diseases, such as type 1 diabetes (T1D), derives from interactions between host genetics and
environmental factors. Previous studies have suggested that viral infection plays a significant role in initiation of T1D in
genetically predisposed individuals. T1D susceptibility loci may therefore be enriched in previously uncharacterized genes
functioning in antiviral defense pathways. To identify genes involved in antiviral immunity, we performed an image-based
high-throughput genetic screen using short hairpin RNAs (shRNAs) against 161 genes within T1D susceptibility loci. RAW
264.7 cells transduced with shRNAs were infected with GFP-expressing herpes simplex virus type 1 (HSV-1) and fluorescent
microscopy was performed to assess the viral infectivity by fluorescence reporter activity. Of the 14 candidates identified
with high confidence, two candidates were selected for further investigation, Il27 and Tagap. Administration of recombinant
IL-27 during viral infection was found to act synergistically with interferon gamma (IFN-c) to activate expression of type I
IFNs and proinflammatory cytokines, and to enhance the activities of interferon regulatory factor 3 (IRF3). Consistent with a
role in antiviral immunity, Tagap-deficient macrophages demonstrated increased viral replication, reduced expression of
proinflammatory chemokines and cytokines, and decreased production of IFN-b. Taken together, our unbiased loss-of-
function genetic screen identifies genes that play a role in host antiviral immunity and delineates roles for IL-27 and Tagap
in the production of antiviral cytokines.
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Introduction
Genome-wide association studies (GWAS) have revolutionized
the study of human genetics and uncovered numerous disease
susceptibility genes and loci over the past decade [1–5], although
the mechanism of how these disease-associated loci/genes may
contribute to the pathogenesis of complex diseases remains largely
unknown. Type 1 diabetes (T1D) is a multifactorial disorder
caused by interactions between genetic and environmental factors
[6]. T1D is an autoimmune disorder characterized by destruction
of insulin-producing b cells in the pancreatic islets. Previous studies
have suggested a role for viruses in T1D susceptibility [7]. Loss or
death of b cells can be achieved by direct targeting of cytotoxic T
cells against virally infected b cells, or indirectly by inflammation
from unrestrained innate immunity [8,9]. The latter mechanism
has been well illustrated by the T1D-associated gene melanoma
differentiation-associated gene 5 (MDA5), also known as interfer-
on-induced helicase 1 (IFIH1), which acts in antiviral defense
[10]. The T1D-associated polymorphism in IFIH1, rs1990760 or
Thr946Ala, has been demonstrated in multiple data sets following
an initial report by Smyth et al. [10]. A subsequent study showed
that individuals homozygous for this risk allele had significantly
higher IFIH1 basal expression and as a consequence, upon
infection, cells were highly activated and produced more
inflammatory cytokines and chemokines [11]. A recent study
identified a chemically induced mutation in Ifih1 in mouse, which
results in constitutive activation of Mda5 and continuous
production of type I interferons accompanied by systemic
inflammation [12]. It is currently unclear if additional T1D-
associated genes alter susceptibility to virus infection and antiviral
defense.
Integrity of host immunity, both innate and adaptive, is central
to antiviral defense. Host immunity is first triggered by the
immediate innate response, which usually starts with recognition
of viral cellular components known as pathogen-associated
PLOS ONE | www.plosone.org 1 September 2014 | Volume 9 | Issue 9 | e108777molecular patterns (PAMPs) by host pathogen recognition
receptors (PRRs) [13–15]. Macrophages, an innate immune cell
type that responds to infections and regulates cellular responses,
express various PRRs that are specific to PAMPs associated with
different pathogens. Viral PAMPs are recognized by several PRRs
including the Toll-like receptors (TLRs), retinoic acid-inducible
gene I (RIG-I)-like receptors (RLRs), and a number of cytosolic
dsDNA sensors [16–20]. In particular, TLR2, a transmembrane
protein expressed on the cell surface, senses viral surface
glycoproteins [21]. Upon entry, the unmethylated CpG motif,
which is a signature of bacterial and viral genomes, is detected by
intracellular TLR9 [22]. TLR3 recognizes dsRNA longer than
30 bp, which has been suggested to be an erroneous byproduct
during massive viral DNA replication [23]. In addition, another
class of cytoplasmic dsRNA sensors, RIG-I and MDA5, recognizes
lengths of dsRNA and 59-triphosphate ssRNA that are absent from
most cytosolic mammalian RNA [24,25]. RIG-I and MDA5
independently signal downstream to an adaptor molecule named
mitochondrial antiviral signaling (MAVS). MAVS subsequently
activates transcription factors including NF-kB, IRF3, and IRF7,
which translocate to the nucleus and upregulate expression of type
I interferons (IFN-a and IFN-b) and interferon-stimulated genes
(ISGs) [26,27]. Additional evidence has also suggested participa-
tion of recently characterized cytosolic dsDNA sensors, including
RNA polymerase III [28], interferon inducible protein 16 (IFI16)
[29], and DNA-dependent activator of interferon regulatory factor
(DAI) [30] in induction of type I IFNs after viral infection. Type I
IFNs and hundreds of ISGs function synergistically to establish an
active antiviral state in host cells [27,31,32].
Herpes simplex virus type 1 (HSV-1) is a dsDNA virus that
belongs to the herpes virus family Herpesviridae. HSV-1 features
high infectivity of macrophages and is recognized by multiple
innate defense pathways including TLR- and RIG-I/MDA5-
dependent pathways [33]. The broad defense pathways triggered
by HSV-1 as well as its high infectivity of macrophages make it
well suited as a model virus to study antiviral pathways. Here we
report an image-based high-throughput genetic screen to identify
uncharacterized genes controlling cellular antiviral immunity and
characterize roles for IL-27 and Tagap in antiviral defense.
Further investigation holds the promise of finding strategies that
enhance the antiviral activity of these genes and developing novel
effective antiviral drugs that work to combat complex diseases as
well.
Results
IFN-c Activates Cellular Antiviral Response in RAW 264.7
Cells
IFN-c is a type II class of interferon and critical player in innate
and adaptive immunity against viral infection [34,35]. It has also
been shown to play an important role in suppression of HSV-1
infection and reactivation from latency [36,37]. Therefore, we
selected HSV-1 as a model viral pathogen to delineate the role of
cellular genes in IFNc-mediated antiviral immunity. First, we
examined whether IFN-c was capable of activating cellular
antiviral activity in RAW 264.7 cells, a mouse leukaemic
monocyte macrophage cell line, upon HSV-1 infection. RAW
264.7 cells were pre-treated with IFN-c for 16 hours before
infection with recombinant HSV-1 expressing GFP (hereafter
HSV-GFP). The GFP expression cassette was under the control of
the Egr-1 promoter and inserted into the intergenic region
between the viral UL3 and UL4 genes [38]. Previous studies have
demonstrated that the presence of the GFP cassette does not have
an impact on viral growth or viral infectivity in cell culture or
animal models [38]. RAW 264.7 cells were infected with HSV-
GFP and the efficiency of viral infection and replication was
determined by the percentage of GFP-positive cells 16 hours post
infection (Figure S1). Dose-dependent viral infectivity was
confirmed by proportional change in the percentage of GFP-
expressing cells (Figure 1A). A 3- to 4-fold reduction in HSV-GFP
infectivity was observed in IFNc-treated cells compared to
untreated cells (Figure 1A and 1B). These results demonstrate
that IFN-c activates the antiviral machinery in RAW 264.7 cells to
suppress HSV-1 replication.
An Image-based shRNA Screen Identifies Gene
Candidates with anti-HSV Activity
To identify T1D-associated genes that are required for antiviral
immunity, we developed an image-based high-throughput assay to
measure the contribution of individual genes to IFNc-mediated
inhibition of viral infection. First, optimal infectivity of HSV-GFP
was titrated as shown in Figure 1A to limit the infection efficiency
to 5–10% with IFN-c priming. Presence of irrelevant non-
targeting shRNA against lacZ or luciferase did not affect the
IFNc-mediated inhibition of HSV-GFP infection (Figure S2A).
However, in RAW 264.7 cells transduced with positive control
shRNAs to knock down gene expression of IFN-c receptor 1
(Ifngr1), 2 (Ifngr2)o rTicam2, the antiviral control by IFN-c was
greatly compromised and a 3- to 4-fold increase of infection
efficiency was observed (Figure S2A and S2B).
Using the conditions described above, a primary genetic screen
was performed in RAW 264.7 cells in 96-well plate format with in-
plate positive and negative shRNA controls in each plate. A
lentivirus-based shRNA library containing 827 lentivirally encod-
ed shRNAs with an average of 5 independent shRNAs targeting
each of the 161 genes within T1D susceptibility loci (see Materials
and Methods) was obtained from The RNAi Consortium (Table
S1). RAW 264.7 cells were transduced with lentiviruses carrying a
single shRNA and puromycin was added to select for transduc-
tants. The surviving transduced cells were allowed to proliferate
for 96 hours before stimulation with IFN-c before HSV infection
(Figure 2A). 16 hours post infection, the HSV infection efficiency
for each individual shRNA-transduced well was measured on an
automated fluorescent microscope. The percentage of GFP-
expressing cells was normalized based on effect size by scaling
between 0 (median of wells transduced with irrelevant shRNA)
and 1 (median of wells transduced with positive control shRNA)
for each individual plate (Figure 2B). After pooling all range-
normalized data together, a Z score for each well was calculated
from the distribution of wells transduced with irrelevant shRNA.
Individual genes were considered to score as positive regulators if 2
or more different shRNAs achieved a Z score equal or greater than
3 standard deviations from the mean for a given gene. Using these
criteria, 34 genes were identified from the primary screen (Table
S2) after exclusion of shRNAs that caused cytotoxicity or whose
targets were not expressed in RAW 264.7 cells.
The screen was repeated with all shRNAs that scored in the
primary screen, and 14 genes were found to have high
reproducibility: Cdk2, Ciita, Dtx3, Esyt1, Gca, Il27, Plxna3,
Prkd2, Rbm17, Skap2, Tagap, Tyk2, Sult1a1, and Clec2d
(Table 1). Representative images are shown in Figure 2C for
shRNA targeting Tagap and Il27. To further validate the
candidate genes, we measured the level of knockdown by the
shRNAs against the 14 candidates using quantitative real-time
PCR (qRT-PCR). For the majority of the candidates, the targeting
shRNA resulted in more than 60% reduction in mRNA levels
compared to irrelevant nontargeting shRNA (Figure S3). 10 of the
candidate genes displayed a direct correlation between the extent
A Genetic Assay Identifies Cellular Antiviral Genes
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replication, suggesting a gene dosage effect. The results for all 5
shRNAs targeting Sult1a1 are shown as an example (Figure 3A).
The rest of the candidates did not show a graded response to
shRNA knockdown, suggesting that for these genes there is a
threshold expression level required for the gene to exert its effect
(Figure 3B). These results strongly suggest that the increased HSV
infectivity is the result of reduced gene expression by targeting
shRNAs and that these genes are involved in antiviral immunity of
RAW 264.7 cells.
A Subset of Candidate Genes are Induced by IFN-c
Priming and HSV Infection
Since the antiviral state of host cells is initiated by pre-treatment
with IFN-c, we next sought to determine whether the candidates
identified from the primary screen were also IFNc-induced genes.
The level of gene expression with or without IFN-c priming, and
upon HSV infection, was measured by qRT-PCR. Among all
candidate genes, 9 genes were constitutively expressed and their
expression was not altered by either IFN-c stimulation or HSV
infection. 5 candidate genes were transcriptionally induced by
IFN-c stimulation and potentially belong to the group of ISGs
(Figure 4). Among the 5 genes, expression of Il27, Tagap, Clec2d,
and Gca could also be independently induced by HSV infection
(Figure 4). This result suggests that these genes are responsive to
viral infection and may play a role in viral detection or viral
defense in host cells.
IL-27 and Tagap Positively Regulate Anti-Viral Responses
against HSV Infection
Of the 14 validated candidates, we chose to focus further
investigation on IL-27 and Tagap due to (1) the strong correlation
Figure 1. Dose-dependent HSV-GFP infectivity in untreated and IFNc-treated RAW 264.7 cells. (A) RAW 264.7 cells were seeded in 96-
well glass-bottom plates at a density of 0.3610
5 cells/well and either left untreated or treated with IFN-c (10 ng/ml) overnight before HSV-GFP
infection at the indicated dilution of viral stock. Note that when the viral stock was diluted 1 to 10, the MOI was 0.5. The average percentage of GFP-
positive cells was calculated from six individual images per treatment condition. Data shown are representative of 3 independent experiments. ***P,
0.001; **P,0.01; *P,0.05 by two-way ANOVA with Bonferroni post-test. (B) Representative images of HSV-GFP infection at 1:25 dilution of the viral
stock. Nuclei stained with Hoechst are shown in blue and HSV-GFP infected cells are shown in green.
doi:10.1371/journal.pone.0108777.g001
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of individual shRNAs that led to the desired phenotype, (3)
potential biological interest, and (4) availability of animal models.
IL-27 is a member of the IL-12 family of cytokines and is mainly
secreted by activated antigen-presenting cells (APCs) such as
dendritic cells and macrophages [39]. IL-27 has a well-character-
ized role in T cell differentiation [40] and has been recently
reported to have antiviral properties [41–43]. To directly assess
the antiviral activity of IL-27 against HSV infection, RAW 264.7
cells were treated with recombinant IL-27 (50 ng/ml) either alone
or in combination with IFN-c. 24 hours later, the cells were then
infected with HSV-GFP, fixed, and imaged as described above.
IL-27 treatment alone did not result in an inhibitory effect on viral
infectivity and priming with IFN-c decreased the viral infectivity
by 46% (Figure 5A). Interestingly, the combination of IFN-c and
IL-27 had an additive effect and resulted in the greatest antiviral
activity.
Upon viral infection, host cells sense viral components through
PRRs and activate antiviral signaling cascades, including the NF-
kB pathway and IFN-responsive pathways. IRF3 plays an essential
role in this process. Upon activation, IRF3, along with its binding
partner IRF7, translocates into the nucleus and binds target DNA
through its DNA-binding domain to activate transcription of genes
including IFNa and IFNb [44,45]. Production of IFNs further
stimulates the activity of other interferon-induced and interferon-
stimulated genes in a positive feedback mechanism. Therefore,
activity of NF-kB and IRF3/7 is an indicator of antiviral immunity
in host cells. To determine whether the inhibitory effect of IL-27 to
HSV infection is achieved through NF-kB, IRF3/7, and IFN
pathways, luciferase-based IRF and NF-kB/IRF reporter cells
were generated in RAW 264.7 cells and the effect of IL-27
treatment was measured by luciferase assay. Treatment of IL-27
alone did not activate either IRF or NF-kB/IRF activity
(Figure 5B). However, consistent with the results shown in
Figure 5A, co-stimulation of IFN-c and IL-27 greatly enhanced
the activities of both reporters (Figure 5B). Furthermore, to show
direct evidence of IFN-c and IL-27-induced antiviral activity, we
examined expression of Ifnb1 as well as proinflammatory
chemokines and cytokines in cells infected with HSV in the
presence or absence of IFN-c and IL-27. Pre-treatment of cells
with IFN-c before HSV infection initiates antiviral signaling
cascades that lead to general production of type I interferons,
proinflammatory chemokines and cytokines (Figure 5C). Ifnb1
and Cxcl10, an IFN-induced gene, were highly induced in
unprimed RAW 264.7 cells upon HSV-1 infection. Ccl3, Ccl5,
Tnfa, and Il6 were expressed at modest levels in unprimed RAW
264.7 cells upon infection, whereas pre-treatment of cells with
IFN-c strongly enhanced HSV1-induced gene expression. Impor-
tantly, with the exception of Cxcl10 and Il6, the response of gene
expression was augmented by addition of IL-27. These data
suggest that administration of IL-27 helps initiate an antiviral
signaling cascade and enhances the immunomodulatory activity of
IFN-c in a positive feedback mechanism during viral infection.
To demonstrate the broad antiviral activity of IL-27, we
infected IRF and NF-kB/IRF reporter cells with Sendai virus, a
ssRNA virus recognized by RIG-I-mediated signaling pathways
[46]. IL-27 alone is capable of suppressing Sendai virus infection
by enhancing the activities of IRF3 and NF-kB (Figure S4).
Unlike IL-27, Tagap has no prior link to IFN signaling or
antiviral immunity. GWAS has identified susceptibility loci in
Tagap, highlighting its role in innate immunity and pathogenesis
of autoimmune diseases [47,48]. To investigate the role of Tagap
Figure 2. Loss-of-function genetic screen identifies positive regulators of antiviral responses. (A) Protocol schematic of the primary
genetic screen. (B) Ranked range normalization plot of the 827 shRNA of interest and controls. Range normalized HSV-GFP infection efficiency for
each individual shRNA-transduced well, expressed as percentage within range 0 to 1, is ranked from low to high and displayed. Green bars indicate
normalized irrelevant shRNA controls and red bars indicate normalized positive controls. Grey bars represent normalized shRNA targeting individual
genes within T1D susceptibility loci. Location of shRNAs with a Z score equal or greater than 3 is indicated by the area shaded in blue. (C)
Representative images are shown for two high-scoring shRNAs that target Tagap and Il27 respectively, and one irrelevant shRNA that targets lacZ.
Hoechst nucleic acid stain indicates the total cells per microscopic field and GFP indicates the virally infected cells.
doi:10.1371/journal.pone.0108777.g002
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by differentiating bone marrow-derived macrophages (BMDMs)
from Tagap-deficient mice in M-CSF-supplemented media.
BMDMs were then infected with two doses of HSV-GFP. After
24 hours, cells were harvested, stained with APC-conjugated GFP
antibody, and analyzed by flow cytometry. Tagap-deficient
Figure 3. The relative expression level of candidate genes is correlated with observed antiviral phenotype. Upper panels: mRNA
expression of Sult1a1 (A) and Il27 (B) in irrelevant shRNA-transduced cells compared to shRNAs against the indicated gene measured by qRT-PCR.
Gapdh was used as internal control for normalization. The results shown are the average from two independent experiments. Lower panels:
percentages of GFP-positive cells after HSV-GFP infection in cells previously transduced with irrelevant shRNA (lacZ and luciferase) or targeting shRNA
for Sult1a1 (A) or Il27 (B). Data shown are representative of 3 independent experiments. ns, not significant; ***P,0.001 compared to negative control
by one-way ANOVA with Dunnett’s post-test.
doi:10.1371/journal.pone.0108777.g003
Table 1. Candidate genes identified from genetic screen.
Symbol NCBI Gene ID Accession number Preferred Gene Name
Cdk2 12566 NM_016756.4 cyclin-dependent kinase 2
Ciita 12265 NM_007575.1 class II transactivator
Dtx3 80904 NM_030714.2 deltex 3
Esyt1 23943 NM_011843.2 extended synaptotagmin-like protein 1
Gca 227960 NM_145523.2 grancalcin
Il27 246779 NM_145636.1 IL27 p28 subunit; interleukin 30
Plxna3 18846 NM_008883.2 plexin 3
Prkd2 101540 NM_178900.2 protein kinase D2
Rbm17 76938 NM_152824.1 RNA binding motif protein 17
Skap2 54353 NM_018773.2 SKAP55 homologue; Srcassociated adaptor protein
Tagap 72536 NM_145968.1 T cell activation Rho GTPase activating protein
Tyk2 54721 NM_018793.2 tyrosine kinase TYK2
Sult1a1 20887 NM_133670.1 Sulfotransferase, 1A, phenol-preferring, member 1
Clec2d 93694 NM_053109.1 osteoclast inhibitory lectin
doi:10.1371/journal.pone.0108777.t001
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2/2) BMDMs were more susceptible to HSV infection
(Figure 6A and 6B). To further demonstrate increased HSV-GFP
infectivity in Tagap
2/2 BMDMs, intracellular HSV-1 RNA was
measured by qRT-PCR. Infected-cell polypeptide 4 (ICP4) and
ICP27 are two of the five immediate early transcriptional
regulatory proteins that are expressed promptly upon HSV-1
infection [49]. ICP4 and ICP27 function to initiate viral DNA
replication and to stimulate the transcription of early and late viral
genes including UL39, which encodes the large subunit of
ribonucleotide reductase [49]. The levels of all three gene
transcripts were increased in Tagap
2/2 BMDMs compared to
WT BMDMs (Figure 6C). Significantly more viral DNA was
detected in Tagap
2/2 BMDMs as well (Figure 6D). Additionally,
levels of viral protein products were compared between WT and
Tagap
2/2 BMDMs by immunobloting and results were consistent
with the qRT-PCR data (Figure 6E). These findings suggest a role
for Tagap in antiviral response.
To assess the influence of Tagap deficiency on innate immune
signaling cascades, expression profiles of type I IFNs, pro-
inflammatory cytokines and chemokines were measured in WT
and Tagap
2/2 BMDMs upon HSV infection. As expected,
Tagap
2/2 BMDMs were defective in several key mediators of the
antiviral response, including IFN-b (Figure 6F). Consistent with
reduced Ifnb1 mRNA level, secreted IFN-b also decreased in
Tagap
2/2 BMDMs after HSV infection (Figure 6G). These
results suggest that Tagap plays a critical role in antiviral signaling
pathways.
Discussion
A number of studies have suggested a connection between
genetic susceptibility to complex disease and viral infection [50–
53]. However, there are only a handful of reports on specific virus-
gene interactions and it remains unclear how many of the genes
within T1D susceptibility loci are associated with antiviral
immunity [54,55]. Placing T1D genes into the viral defense
pathway could help identify therapeutic entry points for T1D
treatment as well as a more complete understanding of the
environmental factors altering disease susceptibility. From the
screen, we identified 14 candidate genes, the differential expres-
sion of which influences the antiviral activity of HSV-1-infected
macrophage cells. However, whether these gene-virus interactions
are sufficient to cause disease requires further investigation.
In an effort to identify novel host restriction factors against
HSV-1 infection, many previous investigations focused on analysis
of large-scale expression data and characterized the genes that are
differentially regulated by IFNs and HSV-1 [56–58]. While this
strategy was successful at identifying host restriction factors, a
number of identified genes collaborate with IFN-induced genes to
construct the antiviral network in host cells. Among the 14
candidates identified from the screen, only 5 were upregulated by
IFN-c and/or HSV-1. This result suggests that a number of
antiviral host defense genes are constitutively expressed and their
activity is only enhanced in the presence of antiviral cytokines such
as IFN-c. While our screening strategy takes an unbiased
approach, due to the use of IFN-c in the screen, the genes that
function in late stage of viral suppression may be undervalued
because the loss of these genes may be rescued or compensated by
the activity of IFN-c and its effector molecules. Regardless, our
screen preserved the integrity of IFN pathways and thus examined
the role of each candidate in the context of an intact antiviral
response which creates a physiologically relevant system.
IFNs are the major cellular restriction factors fighting against
viral infection. IFNs bind to their receptors and activate the
downstream JAK-STAT signaling pathway that further leads to
augmented antiviral responses. Among the 14 candidate genes
identified from the genetic screen, Tyk2, Ciita and IL-27, are
direct targets of IFN activation. Tyk2 belongs to the family of
Janus kinases (JAKs) and is activated in response to type I IFNs
[59]. Tyk2 phosphorylates the transcription factor Stat1 and leads
to a functional type I IFN response [60]. Ciita, class II
Figure 4. Induction of candidate gene expression by IFN-c and HSV-GFP infection. Cells were seeded and either left untreated or treated
with IFN-c (10 ng/ml) for 16 h. HSV-GFP (MOI=0.5) was used to infect the cells as indicated above. qRT-PCR was performed to measure the relative
expression of all candidate genes relative to the untreated control. Gapdh was used as internal control for normalization. Data shown are results from
3 independent experiments. ***P,0.001 compared to untreated control by one-way ANOVA with Dunnett’s post-test.
doi:10.1371/journal.pone.0108777.g004
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class II MHC genes upon stimulation, and consistent with our
results, studies have shown that IFN-c induces expression of Ciita
in a Stat1-dependent manner [61]. Given the functional signifi-
cance of MHC class II molecules in initiation and maximization of
the adaptive immune response, Ciita acts as a bridge between
innate and adaptive immunity, thus playing a critical role in
controlling viral infection. Similar to type I IFNs, IL-27 is also
capable of activating the JAK-STAT pathway and inducing
expression of inflammatory cytokine genes in macrophages
[62,63]. These findings suggest that T1D genes within risk loci
function in a common signaling pathway, which is composed of
IFNs/IL-27, JAK/Tyk2, Stat1, Ciita, and the downstream
effectors. Besides the connection with the JAK-STAT signaling
pathway, a subgroup of the candidate genes (Tyk2, Cdk2, Prkd2,
Sult1a1, Rbm17, and Ciita) are enriched based on DAVID
analysis for nucleotide binding, including adenyl nucleotide/
ribonucleotide binding and ATP binding, a pathway important for
antiviral signaling (Table S3). Although many of the candidate
genes identified from the genetic screen do not seem to possess
direct antiviral properties, 12 of them, with the exception of Il27
and Dtx3, have been shown to be differentially expressed in
peripheral blood mononuclear cells isolated from Ebola virus-
infected nonhuman primates [64]. This result suggests that these
genes may play a role in antiviral pathways or virally induced
cellular processes. Further investigation is required to delineate the
function of individual candidate genes in the context of viral
infection.
Previous reports have shown that IL-27 is induced by a variety
of viruses, including HIV, HBV, influenza A virus, murine
Figure 5. IL-27 functions cooperatively with IFN-c to suppress the infection of HSV-GFP. (A) Cells were seeded in 96-well glass-bottom
plates and either left untreated or treated with recombinant IL-27 alone (50 ng/ml), IFN-c alone (10 ng/ml) or IL-27 + IFN-c for 16 h. After infecting
cells with HSV-GFP overnight, cells were fixed, stained with nuclear acid stain and subjected to imaging. Percentage of GFP-positive cells in each
treatment group was calculated and graphed. Data shown are results from 4 independent experiments. (B) NF-kB/IRF and IRF reporter cells were
seeded and treated as in (A). After stimulating with IL-27 and/or IFN-c for 16 h, cells were lysed and luciferase activities measured. The reporter
luciferase activity in untreated cells is normalized to 1. Data shown are results from 3 independent experiments. (C) Cells were seeded and treated as
in (A). After infecting cells with HSV-GFP for 6 h, RNA was isolated and qRT-PCR was performed to examine the relative expression levels of
downstream effector genes. All expression levels are relative to the level of untreated control and Gapdh was used as internal control for
normalization. Data shown are results from 3 independent experiments. ns, not significant; ***P,0.001; *P,0.05 by one-way ANOVA with Bonferroni
post-test.
doi:10.1371/journal.pone.0108777.g005
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HIV infection, IL-27 mediates viral suppression in human
macrophages in a mechanism similar to IFN-a, which induces
the expression of downstream antiviral molecules such as the
family of APOBEC cytidine deaminases [42]. In our experimental
system, IL-27 alone is not sufficient to induce antiviral immunity,
suggesting that host restriction factors induced by IFN-c cooperate
with IL-27 to boost antiviral immunity to HSV-1 infection.
Recently, IFN-l1, a type III IFN, was shown to be co-induced
with IL-27 by HBV infection and to cooperate with IL-27 to limit
HBV replication in HepG2 cells [69]. Unfortunately, the IFN-l1
gene is a pseudogene in mice [70] and examination of the other
two members of the type III IFN family, IFN-l2 and -l3,
suggested that the coordinated regulation of IL-27 and IFN-l does
not seem to operate in murine macrophage cells upon HSV-1
infection. Taken together, these data suggest that IL-27 can work
in concert with a variety of IFNs to mediate host defense against a
plethora of viruses.
Single nucleotide polymorphisms (SNPs) within the Tagap locus
have been identified as a shared risk factor for Crohn’s disease and
celiac disease, while other SNPs within this locus have been
associated with protection from rheumatoid arthritis and T1D
[71,72]. Tagap is highly expressed in immune cells, including B
cells, T cells, dendritic cells, natural killer cells, and monocytes;
however, little is known about the function of Tagap in host
defense. Our data suggest that Tagap plays a role in regulating key
antiviral cytokines. However, future studies will be important to
define the mechanism of action of Tagap given its broad
association with complex diseases.
In summary, our unbiased loss-of-function genetic screen
identified genes within T1D susceptibility loci that work in concert
with IFN signaling pathways to protect host cells from detrimental
viral infection, thus preventing improper immune responses
leading to inflammation and autoimmunity. Better understanding
of the mechanisms of the gene-plus-virus interaction will provide
new approaches to design therapies to treat complex diseases.
Materials and Methods
Ethics statement
Mice used in this study were maintained in specific-pathogen-
free facilities at Massachusetts General Hospital (Boston, MA). All
animal studies were conducted under protocols approved by the
Institutional Animal Care and Use Committee (IACUC) at
Massachusetts General Hospital. These mice were bred and
experiments were approved under protocol 2007N000045.
Cells, viruses, mice, and reagents
RAW 264.7cells(TIB-71) and Verocells (CCL-81) wereobtained
from ATCC and cultured in DMEM (Gibco) supplemented
Figure 6. Tagap deficiency results in increased susceptibility to HSV-GFP infection in macrophages. (A and B) BMDMs derived from WT
or Tagap
2/2 mice were infected with HSV-GFP at a MOI of 0.2 (HSV_low) or 0.5 (HSV_high). After 12 h, cells were harvested and stained for GFP.
Experiments were performed with a total of 4 mice per genotype. Representative flow plots are shown in (B). ns, not significant; *P=.0463 for
HSV_low; *P=0.0370 for HSV_high. (C) BMDMs were infected with HSV-GFP at a MOI of 0.5. After 10 h, relative mRNA levels of three viral genes (ICP4,
ICP27, and UL39) were measured in WT versus Tagap
2/2 BMDMs. Gapdh was used as internal control for normalization. n=2 with a total of 4 mice per
genotype. **P=0.0032 for ICP4; **P=0.0013 for ICP27; **P=0.0014 for UL39. (D) BMDMs were infected with HSV-GFP at a MOI of 0.5. After 16 h, DNA
was isolated and the relative DNA content of ICP27 in WT versus Tagap
2/2 BMDMs was measured. Rplp0 DNA content was used as internal control
for normalization. n=2 with a total of 4 mice per genotype. ***P,0.0001. (E) BMDMs were infected with HSV-GFP at a MOI of 0.5. After 24 h, Western
blotting was performed using antibodies specific to viral proteins ICP4 and ICP27. b-actin was used as loading control. Representative image from
two independent experiments is shown. (F) BMDMs were infected as in C. After 3 or 6 h, RNA was isolated to measure the relative expression of pro-
inflammatory cytokines or chemokines, respectively. n=2 with a total of 4 mice per genotype. ***P=0.0006 for Ifna; **P=0.0052 for Ifnb1;
**P=0.0063 for Tnfa; *P=0.0123 for Il6; **P=0.0014 for Ccl3; **P=0.0011 for Ccl5; **P=0.0052 for Cxcl10. (G) BMDMs were infected as in (A). After
12 h, culture supernatant was collected and ELISA was performed to measure the amount of secreted IFN-b. n=3 with a total of 6 mice per genotype.
ns, not significant; **P=0.0094 for HSV_low; ***P=0.0003 for HSV_high. All statistical comparisons were performed by unpaired two-tailed t-tests.
doi:10.1371/journal.pone.0108777.g006
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Technologies) and 20 mg/ml gentamycin sulfate (Sigma-Aldrich).
IRF and NF-kB/IRF reporter cells were generated by transducing
RAW 264.7 cells with lentiviral-based firefly luciferase expression
constructs under the control of either IRF consensus sequence
(GAAAACGAAACT) and/or NF-kB consensus sequence
(GGGAAATTCC). Recombinant IL-27 was purchased from
eBioscience and used at a concentration of 50 ng/ml.
The Tagap
2/2 mouse was a kind gift from Dr. Bernhard G.
Herrmann [73]. As reported in the original publication by Bauer
et al., the accession number for the gene targeted in this knockout
model is NM_145968, which corresponds to the Tagap gene.
However, Bauer et al. refer to this gene as Tagap1. To clarify the
gene targeted in these mice, we developed a quantitative RT-PCR
method and showed that the targeted mice lacked Tagap mRNA,
consistent with the accession number referenced in the original
publication (Figure S5). See also MGI ID 3615484 for gene
information and MGI ID 3603008 for mouse strain information.
BMDMs were generated by culturing mouse bone marrow cells
in RPMI (Gibco) supplemented with 10% FBS, 1% GlutaMAX,
20 mg/ml gentamycin sulfate and 20 ng/ml M-CSF (Peprotech)
for 6 days.
HSV-GFP were propagated and titrated in Vero cells. Briefly,
Vero cells were infected with HSV-GFP at low multiplicity of
infection (MOI). Culture supernatant was collected when .95%
cytopathic effect observed and cell debris was removed by
centrifugation. The viral stock was aliquoted and stored at
280uC until use. Virus titer was determined by plaque assay
and crystal violet stain. The virus stock contained 3610
6 plaque-
forming unites (PFU)/ml. In experiments, cells were infected with
HSV-GFP at a MOI of 0.5 or as specified in figure legends.
Sendai virus was purchased from ATCC (VR-105). In
experiments, cells were infected with Sendai virus at a MOI of 1.
Genetic screen
161 genes within T1D susceptibility loci were selected from
genes in T1Dbase (http://www.t1dbase.org). We filtered genes
based on (1) those genes closest to T1D SNPs and (2) expression of
these genes in immune cells based on data from publicly available
databases. The lentivirus-based shRNA library containing 827
shRNA sequences against these 161 genes was obtained from the
RNAi Consortium (Broad Institute). RAW 264.7 cells were seeded
in 96-well flat-bottom plate on day 0 and transduced with
lentiviruses on day 1. On day 2, puromycin (Sigma-Aldrich) was
added to cell culture media at a final concentration of 3 mg/ml.
Cells were fed once with puromycin-containing media on day 5.
On day 6, cells were split and approximately 0.5610
5 cells per well
were seeded in 96-well glass bottom plates (In Vitro Scientific) and
stimulated with mouse IFN-C (Shenandoah Biotechnology) at a
final concentration of 10 ng/ml. On day 7, cells were infected with
HSV-GFP at a MOI of 0.5 for 16 h before fixing with 4%
paraformaldehyde (PFA) (Santa Cruz Biotechnology). Nuclei were
stained with Hoechst 33342 nucleic acid stain (Life Technologies)
for 10 min. Images were collected with 2 emission wavelengths,
GFP for virus and Hoechst for host cell nuclei, by automated
fluorescent microscopy (Molecular Devices). Images for six
microscopic fields per well were captured and analyzed using a
custom pipeline generated from CellProfiler cell image analysis
software [74]. The total number of cells per field was determined
by the number of Hoechst-labeled nuclei. HSV-GFP infection
efficiency per field was determined by the percentage of GFP-
positive cells. The HSV-GFP infection efficiency for each
individual sample that was transduced with different lentiviral
shRNA was determined by the average percentage of GFP-
positive cells from the six images collected from the same well.
Data obtained from each 96-well plate were range-normalized by
scaling between 0 (0%) (computed by the median of wells
transduced with irrelevant shRNA controls) and 1 (100%)
(computed by median of wells transduced with positive control
shRNA). Range normalization was done on per-plate basis, then
all normalized data (expressed as percentage within the range)
were pooled and Z scores calculated individually from the
distribution of normalized irrelevant shRNA controls. shRNAs
with a Z score equal or greater than 3 was considered a ‘‘hit’’ of
the screen.
RNA and DNA isolation and quantitative real-time PCR
RNA isolation was performed using a NucleoSpin 96 RNA
Isolation Kit (Macherey-Nagel) or RNeasy Mini Kit (Qiagen)
according to the manufacturers’ instructions. cDNA was synthe-
sized using the iScript cDNA synthesis kit (Bio-Rad) and qRT-
PCR was performed using iQSYBRGreen super mix (Bio-Rad)
with 300 nM forward and reverse primers in a CFX386 Real-
Time PCR System (Bio-Rad). Relative levels of target mRNA
were normalized to Gapdh mRNA. Viral genomic DNA was
isolated using QuickExtract DNA Extraction Solution (Epicentre).
ICP27 DNA content was measured by qRT-PCR and normalized
to ribosomal protein large P0 (Rplp0). Primers used are listed in
Table S4.
ELISA
Cell culture supernatants were collected 12 h after stimulation.
The concentration of IFN-b was measured using VeriKine Mouse
Interferon Beta ELISA kit (PBL Assay Science) according to the
manufacturer’s instructions.
Flow cytometry
HSV-infected BMDMs were harvested at 12 h as indicated in
figure legends. Following infection, plates were spun at 5006g and
supernatants collected for ELISA. Cells were washed once with
PBS and stained with Live/Dead fixable stain (Invitrogen, Life
Technologies) according to the manufacturer’s instructions. Cells
were harvested by scraping, blocked with Fc block, and stained
with mouse anti CD11b (eBioscience). Cells were then fixed using
Foxp3/Transcription Factor intracellular staining kit (eBioscience)
according to the manufacturer’s instructions. GFP was detected
using Alexa Fluor 647-conjugated anti-GFP (Life Technologies).
Samples were acquired using an LSR OO flow cytometer (BD
Biosciences) and post-acquisition analysis was performed using
FlowJo software (Tree Star Inc.)
Whole cell extract and Western blotting
Cells were lysed in RIPA buffer (25 mM Tris?HCl pH 7.6,
150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS)
supplemented with Protease Inhibitor Cocktail (Roche) and
incubated on ice. The mixture was vortex mixed every 3 min
for 15 min and centrifuged at 13,000 rpm for 10 min at 4uC. The
supernatant was harvested and protein concentration was
measured by BCA Protein Assay Kit (Thermo Scientific Pierce).
After separating on sodium dodecyl sulfate (SDS)–polyacrylamide
gel, proteins were visualized using antibodies specific to HSV-1
ICP4 (H943) and ICP27 (vP-20) (Santa Cruz Biotechnology).
b-actin levels were visualized as a control (Sigma-Aldrich). A
detailed procedure for Western blotting has been described
previously [75].
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Cells were stimulated as described in the text. On the day of
experiment, PrestoBlue Cell Viability Reagent (Life Technologies)
was added to cells and incubated for 20 min. Absorbance was
measured in a SpectraMax M5 Microplate Reader (Molecular
Devices). After reading the plate, culture supernatants were
removed and luciferase activity was determined using SteadyLite
plus Reporter Gene Assay System (PerkinElmer) in TopCount
NXT Microplate Luminescence Counter (PerkinElmer). Relative
reporter activity was normalized to cell viability determined earlier
by PrestoBlue viability assay.
Data analysis
All experiments were repeated independently as indicated in the
figure legends. Averaged or representative results from all repeats
are shown. Statistical analyses are described in figure legends;
significance was defined as P,0.05.
Gene ontology enrichment analysis was performed using the
Database for Annotation, Visualization and Integrated Discovery
(DAVID) [76,77].
Supporting Information
Figure S1 Cell Profiler image analysis pipeline identi-
fies GFP-positive nuclei as HSV-1-infected RAW 264.7
cells. RAW 264.7 cells were seeded in 96-well glass bottom plates
at 0.5610
5 cells/well and infected with HSV-GFP at an MOI of 1.
After 16 h, cells were fixed and stained with Hoechst 33342
nucleic acid stain. Shown are representative images collected by
fluorescent microscopy. A CellProfiler analysis pipeline was
applied to calculate the efficiency of viral infection. Hoechst stain
for dsDNA was used to identify cells and GFP expression indicates
viral infection. The number of GFP-positive nuclei (cells) was
determined for each image.
(PDF)
Figure S2 Knockdown of antiviral genes increases HSV-
GFP infectivity. (A) RAW 264.7 cells were seeded in 96-well flat
bottom plates at low density (0.1610
5 cells/well) and transduced
with lentivirally encoded shRNAs against three key players
involved in antiviral pathways (Ticam2, Ifngr1, and Ifngr2) or
non-targeting controls (lacZ and luciferase). After four days of
puromycin selection, cells were split, seeded in 96-well glass
bottom plates at approximately 0.3610
5 cells/well and stimulated
with IFN-c overnight before infecting with HSV-GFP at an MOI
of 0.5. The average percentage of GFP-positive cells was
calculated from six individual images per sample. Data shown
are representative of 3 independent experiments. ***P,0.0001.
Ticam, Ifngr1, and Ifngr2 were each compared to individual
negative controls by t-tests; Fisher’s exact method was used to
combine individual P values and generate an overall P value for
each tested gene. (B) Representative images of cells transduced
with irrelevant control shRNA against lacZ or positive control
shRNA against Ifngr1. The total number of cells per image was
determined by Hoechst nuclei acid stain and number of HSV-
GFP infected cells was determined by GFP expression. Efficiency
of viral infection was then calculated as the percentage of GFP-
positive cells. Knockdown of Ifngr1 in RAW 264.7 cells results in
approximately 3.5 fold increase in viral infectivity.
(PDF)
Figure S3 Relative expression of candidate genes in
RAW 264.7 cells after transduction with lentivirally
encoded shRNA. Cells were seeded and transduced with
different targeting shRNAs as described in Figure S2. After 96 h
of selection in puromycin-containing media, cells were stimulated
with IFN-c (10 ng/ml) for 16 h. After stimulation, cells were
harvested and RNA was isolated. qRT-PCR was performed to
measure the knockdown of individual candidate gene. Expression
of each candidate gene in cells transduced with irrelevant shRNA
is set to 1. Expression of the same gene in cells transduced with
targeting shRNA is calculated as relative to the irrelevant control.
Gapdh was used as an internal control for normalization. Results
were derived from two independent experiments.
(PDF)
Figure S4 IL-27 enhances the activity of NF-kB and
IRF3/7 in Sendai virus-infected RAW 264.7 cells. NF-kB/
IRF and IRF reporter cells were seeded in 96-well clear bottom
plates at 1610
5 cells per well and either left uninfected or infected
with Sendai virus (SeV) at an MOI of 0.5 in the presence or
absence of recombinant IL-27 (50 ng/ml). After 16 h, cells were
lysed and luciferase activities were measured. The reporter
luciferase activity in untreated cells is normalized to 1. Data
shown are results from 3 independent experiments; error bars
represent standard deviation. ***P,0.0001 by unpaired two-tailed
t-tests.
(PDF)
Figure S5 Tagap and Tagap1 expression in Tagap KO
mice. (A) Primers used for verifying expression of Tagap and
Tagap1 in KO mice. (B–C) Expression of Tagap1 (B) and Tagap
(C) mRNA in total splenocytes from WT, heterozygous (Het), and
KO mice. In (C), expression levels of the WT allele are normalized
to Tagap expression in WT mice; expression levels of the KO
allele are normalized to Tagap expression in KO mice. The
targeted (KO) mice express Tagap1 at levels similar to WT mice,
whereas WT, Het, and KO mice display patterns of expression
consistent with Tagap gene targeting. Thus, the mice described
here lack Tagap expression.
(PDF)
Table S1 List of targeting shRNAs used in the primary
genetic screen. This table includes target sequences, target gene
ID, target gene symbol, region of the gene (CDS, coding sequence;
UTR, untranslated region), and estimated viral titer of lentiviral
particles for each shRNA hairpin.
(XLSX)
Table S2 Percentile rank and Z score of individual
shRNA hairpins that scored in the primary genetic
screen.
(XLSX)
Table S3 Gene ontology enrichment analysis of con-
firmed hits from secondary screens.
(XLSX)
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